Overtreatment of older men with prostate cancer raises concerns

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality of life without extending life, according to a new study led by Cedars-Sinai.

UQ study offers insights into how Haemophilus influenzae manipulates the immune system

Researchers from The University of Queensland have identified how a common bacterium is able to manipulate the human immune system during respiratory infections and cause

July 12, 2024

Risk Adjusted Net Present Value: What is the current valuation of Vor BioPharma’s Tremtelectogene Empogeditemcel

The revenue for Tremtelectogene Empogeditemcel is expected to reach an annual total of $91 mn by 2039 globally based off GlobalData’s Expiry Model. The drug’s

August 28, 2023

Virginia Tech student receives NSF support to pursue new line of research into the health impact of ultra-processed foods

Zach Hutelin, a doctoral candidate in the Virginia Tech’s Translational Biology, Medicine, and Health (TBMH) Graduate Program, has been awarded a prestigious National Science Foundation

August 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.